
In an industry where innovation is measured in saved seconds and improved outcomes, a three-year-old startup has quietly embedded itself into the daily workflow of nearly half of all physicians in the United States, commanding a valuation that rivals established giants. OpenEvidence, an AI-powered medical search tool, recently secured a $250 million funding round that doubled its valuation to a










